Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Measuring insulin levels and insulin resistance in adults with PCOS and obesity

Observes fasting insulin and insulin resistance in adults with PCOS or obesity.

Plain-language title generated from the registry record
Registry title: Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Key facts

Where
Houston, United StatesSee the site

Where in United States

  • Lilli HealthHouston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ali Chappell
Trial code
NCT05950282
Record updated
1 May 2026
Original description
The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.Read full original descriptionShow less

Measuring Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.

Inclusion: Participants must have completed metabolic testing within one month prior to enrollment, including:; Fasting insulin; Hemoglobin A1c (A1c); Complete lipid panel; Triglycerides Laboratory testing must be completed through a healthcare provider, an independent laboratory, or by using an Insara Insulin Testing Kit Laboratory values must be obtained following a minimum 8-hour fast Participants must have complete laboratory data for all required measures.

ClinicalTrials.gov NCT05950282